53 results on '"Oates, John A."'
Search Results
2. In vitro safety pharmacology evaluation of 2-hydroxybenzylamine acetate
3. Evaluating health visitor assessments of mother–infant interactions: A mixed methods study
4. Determination of 3-methoxysalicylamine levels in mouse plasma and tissue by liquid chromatography–tandem mass spectrometry: Application to in vivo pharmacokinetics studies
5. 2009 Focused Update Incorporated Into the ACC/AHA 2005 Guidelines for the Diagnosis and Management of Heart Failure in Adults: A Report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines Developed in Collaboration With the International Society for Heart and Lung Transplantation
6. Macrophage EP4 Deficiency Increases Apoptosis and Suppresses Early Atherosclerosis
7. Treatment of elderly hypertensive patients with epithelial sodium channel inhibitors combined with a thiazide diuretic reduces coronary mortality and sudden cardiac death
8. Synthesis of tetranor-PGE1: A urinary metabolite of prostaglandins E1 and E2
9. The relationship between dose of vitamin E and suppression of oxidative stress in humans
10. Cyclooxygenase-2 promotes early atherosclerotic lesion formation in ApoE-deficient and C57BL/6 mice
11. Quantification of the major urinary metabolite of PGE 2 by a liquid chromatographic/mass spectrometric assay: determination of cyclooxygenase-specific PGE 2 synthesis in healthy humans and those with lung cancer
12. Quantification of the Major Urinary Metabolite of 15-F2t-Isoprostane (8-iso-PGF2α) by a Stable Isotope Dilution Mass Spectrometric Assay
13. 40 - Post-translational modification of ApoA-1 in metabolic syndrome
14. A Patient With Elevated Plasma High Density Lipoprotein (HDL) and Facial Flushing
15. Increased Detection of Herpesvirus DNA in Idiopathic Pulmonary Fibrosis
16. Quantification Of Malondialdehyde Adducts In Platelet Activation As An Indicator Of Proinflammatory and Prothombotic State
17. P3-351: Cyclooxygenase-derived prostanoids modulate α-secretase activity
18. P2-473: Inhibitors of the formation of cyclooxygenase-derived lipid adducts of brain proteins
19. Gregory Robert Mundy, MD (1942–2010)
20. Risk factors for infant attrition and low engagement in experiments and free-play
21. Comparative evaluation of the radioenzymatic method for the determination of urinary histamine with a mass spectrometric assay
22. Effect of solubilization of CO 2 on the critical micelle concentration of sodium alkyl sulfonates
23. Accurate and efficient method for quantification of urinary histamine by gas chromatography negative ion chemical ionization mass spectrometry
24. Identification and assay of tetranor-prostaglandin E1 in human urine
25. Quantification of the major urinary metabolite of prostaglandin D 2 by a stable isotope dilution mass spectrometric assay
26. Quantitative analysis of two dinor urinary metabolites of prostaglandin I 2
27. Operative management of renovascular hypertension: Results after a follow-up of fifteen to twenty-three years
28. On the mechanism of biosynthesis of 5- and 15-series leukotrienes
29. Tartrazine and the prostaglandin system
30. Intervention with epinephrine in hypotension associated with mastocytosis
31. Urinary prostaglandins: Site of entry into renal tubular fluid
32. Evidence for the biotransformation of procainamide to a reactive metabolite
33. Toxicologic enhancement by a combination of drugs which deplete hepatic glutathione: Acetaminophen and doxorubicin (Adriamycin)
34. Metabolism of bufotenine-2′- 14C in human volunteers
35. Platelet dysfunction in the neonate with essential fatty acid deficiency
36. Identification of Skin as a Major Site on Prostaglandin D2 Release Following Oral Administration of Niacin in Humans
37. Biochemical Diagnosis of Systemic Mast Cell Disorders
38. Systematic synthesis of prostaglandin I 2 following sustained infusion of angiotensin II in conscious dogs
39. Hypertension Complicating Essential Thrombocythemia
40. Therapeutic choice in the treatment of hypertension: Initial treatment of newly diagnosed hypertension and secular trends in the prescribing of anti hypertensive medications for medicaid patients
41. Two-dimensional echocardiography in the diagnosis of carcinoid heart disease
42. Cigarette smoking and hemostatic function
43. Bartter's syndrome: A disorder characterized by high urinary prostaglandins and a dependence of hyperreninemia on prostaglandin synthesis
44. Effects of adrenergic neuron-blocking guanidine derivatives on mitochondrial metabolism
45. Pharmacologic and Endocrine Aspects of Carcinoid Syndrome
46. Molecular basis for the antigenicity of lidocaine analogs: Tocainide and mexiletine
47. Suppression of resistant ventricular arrhythmias by twice daily dosing with flecainide
48. METABOLISM OF ARACHIDONIC ACID BY THE CYCLOOXYGENASE PATHWAY IN MAST CELLS AND BY THE 15-LIPOXYGENASE PATHWAY IN HUMAN EOSINOPHILS
49. What's different about babies who ‘fail to provide data’ in habituation experiments?
50. 1138 - EFFECTS OF ORAL ADMINISTRATION OF PROSTAGLANDIN PRECURSORS IN PHARMACOLOGIC DOSES
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.